Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Li

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Molecular Pain|March 15, 2021
Differential modulation of thermal preference after sensitization by optogenetic or pharmacological activation of heat-sensitive nociceptorsJerry Li, Maham Zain, Robert P Bonin
Oncology and Therapy|June 13, 2021
Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer and EGFR-Activating MutationsJerry Li, Dana Nickens, Keith Wilner, et al.
Nature Communications|September 26, 2023
The complexity of NISQSitan Chen, Jordan Cotler, Hsin-Yuan Huang, et al.
Nature Communications|February 12, 2024
Publisher Correction: The complexity of NISQSitan Chen, Jordan Cotler, Hsin-Yuan Huang, et al.
Journal of Medicinal Chemistry|November 13, 2018
Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer TherapyYepeng Luan, Jerry Li, Jean A Bernatchez, et al.
Plos Computational Biology|May 14, 2009
Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitorsLi Xie, Jerry Li, Lei Xie, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 12, 2026
Adaptive Dosing Trial Simulation Framework to Inform Dose Optimization: Case Study Using Longitudinal PKPD Models With PF-06804103 Phase 1 Data in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive and Low Solid TumorsJerry Li, Li Zhou, Abraham C F Leung, et al.
Clinical Pharmacology in Drug Development|December 28, 2020
Pharmacokinetics and Safety of Glasdegib in Participants With Moderate/Severe Hepatic Impairment: A Phase I, Single-Dose, Matched Case-Control StudyJoanna C Masters, Robert R LaBadie, Joanne Salageanu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 9, 2026
Curcumin suppresses HNSCC tumorigenesis through directly targeting FOSL1/JUNJerry Li, Sarita Pandit, Kanakaraju Manupati, et al.
Marine Drugs|August 20, 2013
Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (II)Chunwei Cheng, Yan Liu, Hao Song, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Molecular Pain|March 15, 2021
Differential modulation of thermal preference after sensitization by optogenetic or pharmacological activation of heat-sensitive nociceptorsJerry Li, Maham Zain, Robert P Bonin
Oncology and Therapy|June 13, 2021
Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer and EGFR-Activating MutationsJerry Li, Dana Nickens, Keith Wilner, et al.
Nature Communications|September 26, 2023
The complexity of NISQSitan Chen, Jordan Cotler, Hsin-Yuan Huang, et al.
Nature Communications|February 12, 2024
Publisher Correction: The complexity of NISQSitan Chen, Jordan Cotler, Hsin-Yuan Huang, et al.
Journal of Medicinal Chemistry|November 13, 2018
Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer TherapyYepeng Luan, Jerry Li, Jean A Bernatchez, et al.
Plos Computational Biology|May 14, 2009
Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitorsLi Xie, Jerry Li, Lei Xie, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 12, 2026
Adaptive Dosing Trial Simulation Framework to Inform Dose Optimization: Case Study Using Longitudinal PKPD Models With PF-06804103 Phase 1 Data in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive and Low Solid TumorsJerry Li, Li Zhou, Abraham C F Leung, et al.
Clinical Pharmacology in Drug Development|December 28, 2020
Pharmacokinetics and Safety of Glasdegib in Participants With Moderate/Severe Hepatic Impairment: A Phase I, Single-Dose, Matched Case-Control StudyJoanna C Masters, Robert R LaBadie, Joanne Salageanu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 9, 2026
Curcumin suppresses HNSCC tumorigenesis through directly targeting FOSL1/JUNJerry Li, Sarita Pandit, Kanakaraju Manupati, et al.
Marine Drugs|August 20, 2013
Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (II)Chunwei Cheng, Yan Liu, Hao Song, et al.
Pageof 4